Mesenchymal stem cell transfusion: Possible beneficial effects in COVID-19 patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mesenchymal stem cell transfusion: Possible beneficial effects in COVID-19 patients

Published:2021-12 Issue:6 Volume:60 Page:103237
ISSN:1473-0502
Container-title:Transfusion and Apheresis Science
language:en
Short-container-title:Transfusion and Apheresis Science

Author:

Yiğenoğlu Tuğçe Nur,Başcı Semih^ORCID,Şahin Derya,Ulaş Turgay,Dal Mehmet Sinan,Korkmaz Serdal,Hacıbekiroğlu Tuba,Namdaroğlu Sinem,Erkurt Mehmet Ali,Turgut Burhan,Altuntaş Fevzi

Publisher

Elsevier BV

Subject

Hematology

Reference75 articles.

1. Coronaviruses: a comparative review;McIntosh,1974

2. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003;WHO,2003

3. Respiratory viral infections in children and adolescents with hematological malignancies;Han;Mediterr J Hematol Infect Dis,2019

4. Middle East respiratory syndrome coronavirus (MERS-CoV). World Health Organization. Retrieved 10 April 2017.

5. The outcome of COVID-19 in patients with hematological malignancy;Yigenoglu;J Med Virol,2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of mesenchymal stem cells therapy in COVID-19 patients: a systematic review and meta-analysis of randomized controlled trials;Journal of Translational Medicine;2024-06-08

2. Advancements in engineered mesenchymal stem cell exosomes for chronic lung disease treatment;Journal of Translational Medicine;2023-12-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP